Overview

Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs

Status:
Unknown status
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
This study will determine the efficacy of collagen cross linking for progressive keratoconus and ectasia after lasik. It will try and determine which is a more effective treatment: collagen cross linking alone or collagen cross linking combined with Intacs, a treatment which has already been proven to be effective in decreasing corneal curvature in patients with keratoconus.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yaron S. Rabinowitz M.D.
Treatments:
Riboflavin